New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2013
04:55 EDTALKS, ALKS, ANGO, ANGO, SNSS, SNSS, VHS, VHS, IART, IART, OCR, OCR, BKD, BKD, BAX, BAX, ARIA, ARIARBC Capital to host a conference
Healthcare Conference is being held in New York on February 26-27.
News For ALKS;ANGO;SNSS;VHS;IART;OCR;BKD;BAX;ARIA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 10, 2016
07:15 EDTBAXLeerink to hold a conference
Subscribe for More Information
07:04 EDTALKSAlkermes announces initiation of second Phase 3 study of ALKS 3831
Subscribe for More Information
February 9, 2016
11:32 EDTBKDOptions with increasing put volume
Subscribe for More Information
10:47 EDTBKDBrookdale: Best path forward is to continue to pursue LT growth strategy
Says management, investment committee, board, along with financial and legal advisors, conducted an extensive analysis and thoroughly evaluated a "wide range of alternatives." Says investment committee and board "unanimously determined" that, at this time, the best path forward for Brookdale to enhance shareholder value is to "continue to focus on pursuing our long-term growth strategy" and executing its existing business plan. Says "well positioned" to capitalize on its platform. Comments taken from the Q4 earnings conference call. Brookdale Senior Living is down 15.06% at the conference call continues.
09:07 EDTALKSAlkermes CEO remains optimistic on depression drug, Forbes reports
Subscribe for More Information
February 8, 2016
16:25 EDTBKDBrookdale Senior Living sees FY16 CFFO $2.45-$2.55, consensus $2.62
Subscribe for More Information
16:24 EDTBKDBrookdale Senior Living reports Q4 CFFO 58c, consensus 46c
Subscribe for More Information
06:32 EDTANGOAngioDynamics' Celerity PICC system approved by Health Canada
Subscribe for More Information
February 5, 2016
07:51 EDTALKSWoodford calls Alkermes, Prothena selloffs 'greatly overdone'
British businessman Neil Woodford's Woodford Investment Management said it added to Alkermes (ALKS) and Prothena (PRTA) positions at what it considers to be "extremely attractive valuation levels." In its January letter to investors, the fund says the recent share price moves "look greatly overdone." Woodford also sold its position in GlaxoSmithKline (GSK) and initiated a new stake in Theravance Biopharma (TBPH). The company "retains a valuable economic interest in the future commercial potential of the respiratory franchise being developed in partnership with GlaxoSmithKline," the fund wrote. It also has "some very interesting, albeit earlier-stage, assets in therapeutic areas such as chronic obstructive pulmonary disease, cardiovascular & renal disease," it added. Woodford made no mention of Northwest Biotherapeutics (NWBO) in the letter, a company he invested in last year. Woodford Investment Management, established in 2014, describes itself as the "the opportunity for Neil Woodford, one of the UK's most highly-regarded fund managers, to distil his 30 years of experience and learning into a business founded on his own principles." Reference Link
February 2, 2016
09:24 EDTBAXBaxter: 1Q16 should be weakest quarter of FY16
Subscribe for More Information
08:59 EDTALKSLeerink views doc checks as positive for ACADIA, Neurocrine
Subscribe for More Information
08:53 EDTBAXBaxter sees FY16 CapEx $900M
Says does not anticipate any sales in 2016 in IPS. Sees FY16 surgical franchise sales growth 2%-3%. Sees FY16 renal business sales growth roughly 3%. Sees FY16 operating margin roughly 11%. Sees FY16 interest expense roughly $90M. Sees FY16 adjusted tax rate 19%-20%. Sees FY16 average share count roughly 540M shares. Sees FY16 CapEx $900M. Sees FY16 free cash flow $500M. Sees FY16 operating cash flow roughly $1.4B. Guidance taken from Q4 earnings conference call.
07:04 EDTBAXBaxter sees FY16 EPS ex-items $1.46-$1.54, consensus $1.42
Subscribe for More Information
07:03 EDTBAXBaxter sees Q1 EPS ex-items 28c-30c, consensus 32c
Subscribe for More Information
07:02 EDTBAXBaxter reports Q4 adjusted EPS 43c, consensus 32c
Subscribe for More Information
February 1, 2016
14:32 EDTBAXNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Exxon Mobil (XOM), consensus 64c... Pfizer (PFE), consensus 52c... United Parcel Service (UPS), consensus $1.42... Dow Chemical (DOW), consensus 70c... Emerson Electric (EMR), consensus 51c... Archer-Daniels-Midland (ADM), consensus 66c... Baxter (BAX), consensus 32c... Sirius XM (SIRI), consensus 3c... Royal Caribbean Cruises (RCL), consensus 92c... Ally Financial (ALLY), consensus 51c... Michael Kors (KORS), consensus $1.46... ADT Corp. (ADT), consensus 46c.
08:09 EDTBAXOptions expected to be active
Options expected to be active: GOOGL GOOG YHOO UPS KORS UPS BAX RCL CCL PFE AET D STR DWA CMG ABT SYK.
07:37 EDTARIAARIAD announces FDA clearance to begin development of AP32788
Subscribe for More Information
January 29, 2016
12:25 EDTBAXBaxter volatility elevated into Q4 and outlook
Subscribe for More Information
07:59 EDTALKSAlkermes management to meet with JPMorgan
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use